Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials

INTRODUCTION: In addition to the lipid-lowering effect of bile acid sequestrants (BASs), they also lower blood glucose and, therefore, could be beneficial in the treatment of patients with type 2 diabetes mellitus (T2DM). Three oral BASs are approved by the US Food and Drug Administration (FDA) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Morten, Sonne, David Peick, Mikkelsen, Kristian Hallundbæk, Gluud, Lise Lotte, Vilsbøll, Tina, Knop, Filip Krag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2012
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533035/
https://www.ncbi.nlm.nih.gov/pubmed/23148345
http://dx.doi.org/10.1136/bmjopen-2012-001803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533035/
https://www.ncbi.nlm.nih.gov/pubmed/23148345
http://dx.doi.org/10.1136/bmjopen-2012-001803

Ejemplares similares